These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8819305)

  • 1. Disposition of the opioid antagonist, nalmefene, in rat and dog.
    Murthy SS; Mathur C; Kvalo LT; Lessor RA; Wilhelm JA
    Xenobiotica; 1996 Jul; 26(7):779-92. PubMed ID: 8819305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a novel morphinan 3-O-diglucuronide metabolite from dog urine.
    Dixon R; Hsiao J; Hsu HB; Smulkowski M; Tze-Ming-Chan ; Pramanik B; Morton J
    Pharm Res; 1989 Jan; 6(1):28-32. PubMed ID: 2717513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liver disease on the disposition of the opioid antagonist nalmefene.
    Frye RF; Matzke GR; Schade R; Dixon R; Rabinovitz M
    Clin Pharmacol Ther; 1997 Jan; 61(1):15-23. PubMed ID: 9024170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene.
    Matzke GR; Frye RF; Alexander AC; Reynolds R; Dixon R; Johnston J; Rault RM
    J Clin Pharmacol; 1996 Feb; 36(2):144-51. PubMed ID: 8852390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans.
    Chandrasekaran A; Tong Z; Li H; Erve JC; DeMaio W; Goljer I; McConnell O; Rotshteyn Y; Hultin T; Talaat R; Scatina J
    Drug Metab Dispos; 2010 Apr; 38(4):606-16. PubMed ID: 20053817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age on the pharmacokinetics of the opioid antagonist nalmefene.
    Frye RF; Matzke GR; Jallad NS; Wilhelm JA; Bikhazi GB
    Br J Clin Pharmacol; 1996 Sep; 42(3):301-6. PubMed ID: 8877019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic nalmefene prodrugs to achieve a one-month sustained release.
    Gaekens T; Guillaume M; Borghys H; De Zwart LL; de Vries R; Embrechts RC; Vermeulen A; Megens AA; Leysen JE; Herdewijn P; Annaert PP; Atack JR
    J Control Release; 2016 Jun; 232():196-202. PubMed ID: 27107723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparison.
    Veng-Pedersen P; Wilhelm JA; Zakszewski TB; Osifchin E; Waters SJ
    J Pharm Sci; 1995 Sep; 84(9):1101-6. PubMed ID: 8537889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.
    Ingman K; Hagelberg N; Aalto S; Någren K; Juhakoski A; Karhuvaara S; Kallio A; Oikonen V; Hietala J; Scheinin H
    Neuropsychopharmacology; 2005 Dec; 30(12):2245-53. PubMed ID: 15956985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nalmefene: intravenous safety and kinetics of a new opioid antagonist.
    Dixon R; Howes J; Gentile J; Hsu HB; Hsiao J; Garg D; Weidler D; Meyer M; Tuttle R
    Clin Pharmacol Ther; 1986 Jan; 39(1):49-53. PubMed ID: 3943269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog].
    Li H; Zhao SF; Wang N; Ge ZH
    Yao Xue Xue Bao; 1996; 31(4):254-7. PubMed ID: 9208648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection.
    Papich MG; Narayan RJ
    Drug Deliv Transl Res; 2022 Feb; 12(2):376-383. PubMed ID: 34817831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of nalmefene in plasma by high-performance liquid chromatography with electrochemical detection and its application in pharmacokinetic studies.
    Chou JZ; Albeck H; Kreek MJ
    J Chromatogr; 1993 Apr; 613(2):359-64. PubMed ID: 8491826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a sensitive liquid chromatographic/tandem mass spectrometric method to pharmacokinetic study of nalmefene in humans.
    Li P; Chen X; Dai X; Wen A; Zhang Y; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):479-84. PubMed ID: 17329173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety study.
    Rosen DA; Morris JL; Rosen KR; Nelson ER; Steelman RJ; Gustafson RA; Wilhelm JA; Chang CT; Thackara JW; Frye RF
    Pharmacotherapy; 2000 Jul; 20(7):745-9. PubMed ID: 10907964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW; Smulkowski M; Dixon R; Tuttle R
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism.
    Costantini LC; Kleppner SR; McDonough J; Azar MR; Patel R
    Int J Pharm; 2004 Sep; 283(1-2):35-44. PubMed ID: 15363499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of nalmefene after a single or multiple intravenous doses in Chinese healthy volunteers].
    Liao RF; Zeng ZP; Wen YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1816-9. PubMed ID: 18971181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and pharmacokinetic studies following oral administration of famciclovir to the rat and dog.
    Filer CW; Ramji JV; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE
    Xenobiotica; 1995 May; 25(5):477-90. PubMed ID: 7571721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.